About BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals is a company based in Mumbai (India) founded in 2003 by Dharmesh Shah. BDR Pharmaceuticals Internationals has raised $88.16 million across 1 funding round from investors including BKT Tires, State Bank of India and Multiples Alternate Asset Management. The company has 1,864 employees as of October 31, 2024. BDR Pharmaceuticals Internationals offers products and services including API, Formulations, and Pellets. BDR Pharmaceuticals Internationals operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, Aurobindo Pharma and Asymchem, among others.
- Headquarter Mumbai, India
- Employees 1864 as on 31 Oct, 2024
- Founders Dharmesh Shah
- Stage Soonicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bdr Pharmaceuticals Internationals Pvt. Ltd.
-
Annual Revenue
$134.65 M (USD)8as on Mar 31, 2024
-
Net Profit
$28.89 M (USD)16as on Mar 31, 2024
-
EBITDA
$43.81 M (USD)16as on Mar 31, 2024
-
Total Equity Funding
$88.16 M (USD)
in 1 rounds
-
Latest Funding Round
$88.16 M (USD), Private Equity Round
Jan 24, 2022
-
Investors
BKT Tires
& 9 more
-
Employee Count
1864
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals offers a comprehensive portfolio of products and services, including API, Formulations, and Pellets.
Manufactures niche APIs with advanced facilities for quality compliance.
Develops and markets various dosage forms for affordable healthcare.
Creates sustained-release pellets using innovative technologies.
People of BDR Pharmaceuticals Internationals
Unlock access to complete
Unlock access to complete
Funding Insights of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals has successfully raised a total of $88.16M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $88.16 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include BKT Tires, State Bank of India and Multiples Alternate Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment partnerships, entrepreneur support, and profit-focused services in finance.
|
Locked | Locked | Locked | |
|
Schools and pre-schools are established in India and abroad.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on early-stage companies
|
Locked | Locked | Locked |
Investor details for BDR Pharmaceuticals Internationals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BDR Pharmaceuticals Internationals
Investment portfolio details for BDR Pharmaceuticals Internationals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BDR Pharmaceuticals Internationals
Detailed financials for BDR Pharmaceuticals Internationals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bdr Pharmaceuticals Internationals Comparisons
Peer comparison for BDR Pharmaceuticals Internationals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, Aurobindo Pharma and Asymchem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of BDR Pharmaceuticals Internationals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bdr Pharmaceuticals Internationals
Complete news archive for BDR Pharmaceuticals Internationals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals was founded in 2003 and raised its 1st funding round 19 years after it was founded.
BDR Pharmaceuticals Internationals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
BDR Pharmaceuticals Internationals is a funded company, having raised a total of $88.16M across 1 funding round to date.
As of Oct 31, 2024, the latest employee count at BDR Pharmaceuticals Internationals is 1,864.
Annual revenue of BDR Pharmaceuticals Internationals is $134.65M as on Mar 31, 2024.
BDR Pharmaceuticals Internationals was established in 2003 in Mumbai, India. Active pharmaceutical ingredients are developed and produced, alongside finished formulations. New drug delivery systems and generic versions are created for therapeutic segments including oncology, critical care, gynecology, respiratory conditions, antidiabetics, neurology, and additional categories. Manufacturing sites are certified under WHO-GMP standards.
BDR Pharmaceuticals Internationals's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
BDR Pharmaceuticals Internationals offers API, Formulations, and Pellets.
BDR Pharmaceuticals Internationals has 10 investors. Key investors include BKT Tires, State Bank of India, Multiples Alternate Asset Management, Kama Holdings, and Nishant Agarwal.
The valuation of BDR Pharmaceuticals Internationals is $950.33M as of Jan 2022.